GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
A phase 1/2 trial of Pembrolizumab, Cisplatin, Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Genmab, active and no longer recruiting.
Overview
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors is a phase 1/2 interventional study registered as NCT04083599 by Genmab, with 350 participants enrolled, started 2019-09-17 and due to reach its primary completion in 2025-12-30. Interventions recorded: GEN1042, Pembrolizumab, Cisplatin, Carboplatin, 5-FU. Conditions listed: Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Shares Genmab, Cisplatin, Carboplatin, Head and neck squamous cell carcinoma.
- TrialStudy of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participan
Shares Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin, Pembrolizumab.
- TrialA Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin.
- TrialStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin.
- TrialStudy of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin.
- TrialAK129 Combination Therapy for Advanced Solid Tumors
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Paclitaxel / nab-paclitaxel, Carboplatin, Head and neck squamous cell carcinoma.
- TrialA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Sm
Shares Gemcitabine, Cisplatin, Carboplatin, Pembrolizumab.
- TrialA Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advance
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Pembrolizumab, Small-cell lung cancer.